Abstract
Sex steroids can influence the metabolism of coagulation and fibrinolysis variables and change their plasma concentration. These effects have been documented with various formulations of oral contraceptives (OCs) and variations in effect of different formulations have been observed (Task Force on Oral Contraceptives 1991).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Abbate R, Pinto S, Rustagno C, Bruni V, Rosati D, Mariani G (1990) Effects of long-term gestodene-containing oral contraceptive administration on hemostasis. Am J Obstet Gynecol 163: 424–430
Astrup T (1958) The haemostatic balance. Thromb Diath Haemorrh 2:347–357 Bertina RM (1988) Prevalence of hereditary thrombophilia and the identification of genetic risk factors. Fibrinolysis 2 (suppl 2): 7–13
Consensus Development Meeting: metabolic aspects of oral contraceptives of relevance for cardiovascular diseases. Am J Obstet Gynecol 162:13351337
Engesser L (1988) Disorders of blood coagulation and fibrinolysis. Thesis, Leiden
Engesser L, Broekmans AW, Briët E, Brommer RIP, Bertina RM (1987) Hereditary protein S deficiency: clinical manifestations. Ann Intern Med 106: 677–682
Gevers Leuven JA, Kluft C, Bertina RM, Hessel LW (1987) Effects of two low-dose oral contraceptives on circulating components of the coagulation and fibrinolytic systems. J Lab Clin Med 109: 631–636
Gevers Leuven JA, Kluft C, Dersjant-Roorda MC, Harthoorn-Lasthuizen El, Peters FPAMN, Bernsen MJ, Helmerhorst FM (1990) Changes in coagulation and fibrinolysis variables during use of two oral contraceptives containing the same dose of ethinyl estradiol and either gestodene or desogestrel. In: Elstein M (Ed) Current status of oral contraception and new developments. Advances in Contraception 6 suppl:69–73
Gram J, Munkvad S, Jespersen J (1990) Enhanced generation and resolution of fibrin in women above the age of 30 years using oral contraceptives low in estrogen. Am J Obstet Gynecol 163: 438–442
Heijboer H, Brandjes DPM, Sturk A, Buller HR, Ten Cate JW (1990) Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. N Engl J Med 323: 1512–1516
Jespersen J, Petersen KR, Skouby SO (1990) Effects of newer oral contraceptives on the inhibition of coagulation and fibrinolysis in relation to dosage and type of steroid. Am J Obstet Gynecol 163: 396–403
Kooistra T, Bosma PJ, Jespersen J, Kluft C (1990) Studies on the mechanism of action of oral contraceptives with regard to fibrinolytic variables. Am J Obstet Gynecol 163: 404–412
Mannucci PM, Tripodi A, Bottasso B, Baudo F, Finazzi G, De Stefano V, Palareti G, Manotti C, Mazzucconi MG, Castaman G (1992) Markers of procoagulant imbalance in patients with inherited thrombophilic syndromes. Thromb Haemostas 67: 200–202
Otter M, Kuiper J, Van Berkel TJC, Rijken DC (1992) Mechanisms of tissue-type plasminogen activator (t-PA) clearance by the liver. Ann New York Acad Sci, in press
Task Force on Oral Contraceptives (1991) A multicentre study of coagulation and haemostatic variables during oral contraception: variations with four formulations. Br J Obstet Gynecol 98: 1117–1128
Winkler UH, Koslowski S, Oberhoff C, Schindler EM, Schindler AE (1991) Changes of the dynamic equilibrium of hemostasis associated with the use of low-dose oral contraceptives: a controlled study of cyproterone acetate containing oral contraceptives combined with either 35 or 50 µg ethinyl estradiol. Advances in Contraception 7 suppl 3: 273–284
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Kluft, C., Leuven, J.A.G., Helmerhorst, F.M. (1992). Studies on the Mechanisms of Action of Steroids on Coagulation and Fibrinolysis. In: Ramwell, P.W., Rubanyi, G.M., Schillinger, E. (eds) Sex Steroids and the Cardiovascular System. Schering Foundation Workshop, vol 5. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-02764-6_6
Download citation
DOI: https://doi.org/10.1007/978-3-662-02764-6_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-02766-0
Online ISBN: 978-3-662-02764-6
eBook Packages: Springer Book Archive